Gene · 2810
SFN: stratifin
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. SFN: stratifin. Genes, record 2810. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2810
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P31947 | 14-3-3 protein sigma | 248 | 524 | Ensembl, GeneID, HGNC |
Source UniProt
Patents95
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641202 A2 | 2025-10-29 | 5142 | P31947 | Espacenet |
| US 12275779 B2 | 2025-04-15 | 39 | P31947 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5142 | P31947 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 8568 | P31947 | Espacenet |
| US 11988676 B2 | 2024-05-21 | 1 | P31947 | Espacenet |
| JP 2024038290 A | 2024-03-19 | 1 | P31947 | Espacenet |
| JP 2023123507 A | 2023-09-05 | 346 | P31947 | Espacenet |
| JP 2023116581 A | 2023-08-22 | 64 | P31947 | Espacenet |
| JP 2023531521 A | 2023-07-24 | 1 | P31947 | Espacenet |
| JP 2023064789 A | 2023-05-12 | 100 | P31947 | Espacenet |
1 to 10 of 95
See all 95 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,327
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SFN papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 37 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 8 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 5 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 5 | 2025 |
| P30CA022453 | CANCER CENTER SUPPORT GRANT | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
| R01GM147696 | Systematic stabilization of specific protein-protein interactions | 4 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 3 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,327Source NIH's project files
See all 1,327 nih grantsPapers2,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Covalent Stabilizers of the Interaction Between 14-3-3σ and Estrogen Receptor‑α. | ACS Med Chem Lett | 2026 | 42741630 | PubTator, text mining | PubMed |
| A Molecular Mechanistic Deep Dive into 14-3-3 Molecular Glue Cooperativity. | Biochemistry | 2026 | 42689535 | PubTator, text mining | PubMed |
| Senescence and Hypoxia Regulate Colon Cancer Cell Transcriptome and Secretome: Insights into Cancer Cell Senescence Pathophysiology. | Biomolecules | 2026 | 42650831 | PubTator, text mining | PubMed |
| Targeting FUNDC1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Suppressing Mitochondrial Function. | Curr Gene Ther | 2026 | 42634168 | PubTator, text mining | PubMed |
| Stress-specific 14-3-3-client modules in digestive cancers: an evidence-graded review of adaptive survival and therapy resistance. | Cancer Biol Ther | 2026 | 42507757 | PubTator, text mining | PubMed |
| YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasis. | Cancer Heterog Plast | 2026 | 42441024 | PubTator, text mining | PubMed |
| RNF126 in Physiology and Disease: A Multifunctional RING-Type E3 Ubiquitin Ligase in Protein Homeostasis, DNA Repair, and Cancer. | Cells | 2026 | 42439634 | PubTator, text mining | PubMed |
| In silico study of 14-3-3σ and Nipah virus W proteins interaction. | Sci Rep | 2026 | 42277131 | PubTator, text mining | PubMed |
| Retinal vasculature-derived proteins serve as potential systemic biomarkers for diabetic retinopathy. | BMJ Open Ophthalmol | 2026 | 42225355 | PubTator, text mining | PubMed |
| Chronic TGFβ1 Signaling Drives Aberrant Alveolar-Basaloid Metaplasia through a KRT17-Stratifin migratory complex. | bioRxiv | 2026 | 42182417 | PubTator, text mining | PubMed |
1 to 10 of 2,367
See all 2,367 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2810
GET https://conductscience.org/api/genes/v1/2810/patents?page=2